Tag Archives: OIG

Revenue impacts: Physician activity now under OIG scrutiny

Revenue impacts: Physician activity now under OIG scrutiny

By Shawn Stevison The Department of Health and Human Services (HHS) Office of Inspector General (OIG) routinely issues new Work Plan items. This year, the OIG has added two items to the Work Plan that directly impact physicians and their practices. In December 2017, the OIG added an item focused on looking at “Financial Relationships

Lexington lawyers discuss their experience combating healthcare fraud at the U.S. Attorney’s Office

By Ben Keeton Healthcare fraud costs the United States tens of billions of dollars each year. Healthcare fraud schemes continue to grow in complexity and seriousness. Kerry Harvey and Andrew Sparks, both with Dickinson Wright, in Lexington, Ky. have a long history of fighting healthcare fraud. Before joining Dickinson Wright, they were with the U.S.

Compounding pharmacies: Data analytics bull’s eye is on you.

By Shawn Stevison The Office of Inspector General (OIG) recently completed an analysis regarding payments for DME infusion drugs, as well as an issuance in June 2016 of the “High Part D Spending on Opioids and Substantial Growth in Compounded Drugs Raise Concerns.” If you are not familiar with those two reports from HHS OIG,

Pharmacy Fraud And Abuse

Operationalizing The New OIG Final Rule In An Integrated Care Environment By: Todd Nova, Gina Geheb and Julie Lappas The role of pharmacists and pharmacies as integral cogs in the patient care continuum continues to grow, thanks in no small part to incentives encouraging integrated and coordinated care designed to enable improved outcomes at lower